MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheldon, L. A.
Right arrow Articles by Hager, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheldon, L. A.
Right arrow Articles by Hager, G. L.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, December 1999, p. 8146-8157, Vol. 19, No. 12
0270-7306/99/$04.00+0

A Ligand Binding Domain Mutation in the Mouse Glucocorticoid Receptor Functionally Links Chromatin Remodeling and Transcription Initiation

Lynn A. Sheldon,1,* Catharine L. Smith,2 Jack E. Bodwell,1 Allan U. Munck,1 and Gordon L. Hager2

Department of Physiology, Dartmouth Medical School, Lebanon, New Hampshire 03756,1 and Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, Bethesda, Maryland 208922

Received 6 August 1999/Returned for modification 10 September 1999/Accepted 15 September 1999

We utilized the mouse mammary tumor virus (MMTV) long terminal repeat (LTR) in vivo to understand how the interaction of the glucocorticoid receptor (GR) with a nucleosome-assembled promoter allows access of factors required for the transition from a repressed promoter to a derepressed, transcriptionally competent promoter. A mutation (C644G) in the ligand binding domain (LBD) of the mouse GR has provided information regarding the steps required in the derepression/activation process and in the functional significance of the two major transcriptional activation domains, AF1 and AF2. The mutant GR activates transcription from a transiently transfected promoter that has a disordered nucleosomal structure, though significantly less well than the wild-type GR. With an integrated, replicated promoter, which is assembled in an ordered nucleosomal array, the mutant GR does not activate transcription, and it fails to induce chromatin remodeling of the MMTV LTR promoter, as indicated by nuclease accessibility assays. Together, these findings support a two-step model for the transition of a nucleosome-assembled, repressed promoter to its transcriptionally active, derepressed form. In addition, we find that the C-terminal GR mutation is dominant over the transcription activation function of the N-terminal GR activation domain. These findings suggest that the primary activation function of the C-terminal activation domain is different from the function of the N-terminal activation domain and that it is required for derepression of the chromatin-repressed MMTV promoter.

* Corresponding author. Mailing address: Department of Physiology, 750W Borwell, 1 Medical Center Dr., Dartmouth Medical School, Lebanon, NH 03756. Phone: (603) 650-7734. Fax: (603) 650-6130. E-mail: Lynn.A.Sheldon.{at}Dartmouth.edu.

Molecular and Cellular Biology, December 1999, p. 8146-8157, Vol. 19, No. 12
0270-7306/99/$04.00+0


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 1999 by the American Society for Microbiology. All rights reserved.